A citation-based method for searching scientific literature


List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS.
V G ALLFREY, R FAULKNER, A E MIRSKY. Proc Natl Acad Sci U S A 1964
100



Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Laura Bonapace, Marie-May Coissieux, Jeffrey Wyckoff, Kirsten D Mertz, Zsuzsanna Varga, Tobias Junt, Mohamed Bentires-Alj. Nature 2014
342
50

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
50

Myeloid-Derived Suppressor Cells.
Dmitry I Gabrilovich. Cancer Immunol Res 2017
613
50

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.
Bin Zhang, Zhijun Wang, Liangliang Wu, Meng Zhang, Wei Li, Jianhua Ding, Jun Zhu, Huafeng Wei, Ke Zhao. PLoS One 2013
167
50

An organellar nα-acetyltransferase, naa60, acetylates cytosolic N termini of transmembrane proteins and maintains Golgi integrity.
Henriette Aksnes, Petra Van Damme, Marianne Goris, Kristian K Starheim, Michaël Marie, Svein Isungset Støve, Camilla Hoel, Thomas Vikestad Kalvik, Kristine Hole, Nina Glomnes,[...]. Cell Rep 2015
62
50

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.
Laura Gatti, Alexandra Sevko, Michelandrea De Cesare, Noemi Arrighetti, Giacomo Manenti, Emilio Ciusani, Paolo Verderio, Chiara M Ciniselli, Denis Cominetti, Nives Carenini,[...]. Oncotarget 2014
16
50

Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation.
Wei-Cheng Tseng, Ming-Tsun Tsai, Nien-Jung Chen, Der-Cherng Tarng. Int J Mol Sci 2020
5
50

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure.
Johanna K Freundt, Gerrit Frommeyer, Tilmann Spieker, Fabian Wötzel, Jochen Schulze Grotthoff, Jörg Stypmann, Georg Hempel, Michael Schäfers, Andreas H Jacobs, Lars Eckardt,[...]. BMC Pharmacol Toxicol 2019
7
50

Histone deacetylase is a target of valproic acid-mediated cellular differentiation.
Nadia Gurvich, Oxana M Tsygankova, Judy L Meinkoth, Peter S Klein. Cancer Res 2004
345
50

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
C Marcela Diaz-Montero, Mohamed Labib Salem, Michael I Nishimura, Elizabeth Garrett-Mayer, David J Cole, Alberto J Montero. Cancer Immunol Immunother 2009
842
50

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment.
Young-Dae Kim, Sang-Min Park, Hae Chan Ha, A Reum Lee, Heeyoung Won, Hyunju Cha, Sangsook Cho, Joong Myung Cho. J Cancer 2020
18
50



Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
Eun-Hye Hong, Eun-Young Heo, Jae-Hyoung Song, Bo-Eun Kwon, Jae-Young Lee, Yaejeong Park, Jinwoong Kim, Sun-Young Chang, Young-Won Chin, Sang-Min Jeon,[...]. Oncotarget 2017
8
50

Acetylation and deacetylation of non-histone proteins.
Michele A Glozak, Nilanjan Sengupta, Xiaohong Zhang, Edward Seto. Gene 2005
50

Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Yan Song, Paul Richardson, Noopur Raje, Nikhil C Munshi, Kenneth C Anderson. Leukemia 2018
47
50

Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Neha Kamran, Padma Kadiyala, Meghna Saxena, Marianela Candolfi, Youping Li, Mariela A Moreno-Ayala, Nicholas Raja, Diana Shah, Pedro R Lowenstein, Maria G Castro. Mol Ther 2017
66
50

Histone deactylase gene expression profiles are associated with outcomes in blunt trauma patients.
Martin Sillesen, Ted Bambakidis, Simone E Dekker, Rasmus Fabricius, Peter Svenningsen, Peter James Bruhn, Lars Bo Svendsen, Jens Hillingsø, Hasan B Alam. J Trauma Acute Care Surg 2016
13
50


Anticancer activities of histone deacetylase inhibitors.
Jessica E Bolden, Melissa J Peart, Ricky W Johnstone. Nat Rev Drug Discov 2006
50


Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
Li Shen, Michael Ciesielski, Swathi Ramakrishnan, Kiersten M Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert Fenstermaker, Roberto Pili. PLoS One 2012
109
50

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
50

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Filippo Veglia, Emilio Sanseviero, Dmitry I Gabrilovich. Nat Rev Immunol 2021
28
50

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Irene de Miguel, Raquel Ordoñez, Leire Garate, Estíbaliz Miranda, Elena Sáez, Amaia Vilas-Zornoza,[...]. J Med Chem 2021
1
100



SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis.
Guangwei Liu, Yujing Bi, Bo Shen, Hui Yang, Yan Zhang, Xiao Wang, Huanrong Liu, Yun Lu, Jiongbo Liao, Xi Chen,[...]. Cancer Res 2014
98
50

Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.
Li Shen, Ashley Orillion, Roberto Pili. Epigenomics 2016
43
50

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.
M Göttlicher, S Minucci, P Zhu, O H Krämer, A Schimpf, S Giavara, J P Sleeman, F Lo Coco, C Nervi, P G Pelicci,[...]. EMBO J 2001
50

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
Vincenzo Bronte, Paolo Serafini, Alessandra Mazzoni, David M Segal, Paola Zanovello. Trends Immunol 2003
375
50

Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.
Yungang Wang, Kai Yin, Jie Tian, Xueli Xia, Jie Ma, Xinyi Tang, Huaxi Xu, Shengjun Wang. Adv Sci (Weinh) 2019
43
50

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
Alejandro Villagra, Fengdong Cheng, Hong-Wei Wang, Ildelfonso Suarez, Michelle Glozak, Michelle Maurin, Danny Nguyen, Kenneth L Wright, Peter W Atadja, Kapil Bhalla,[...]. Nat Immunol 2009
286
50

Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.
Brian R Rosborough, Antonino Castellaneta, Sudha Natarajan, Angus W Thomson, Heth R Turnquist. J Leukoc Biol 2012
47
50

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.
Brian J Christmas, Christine I Rafie, Alexander C Hopkins, Blake A Scott, Hayley S Ma, Kayla A Cruz, Skylar Woolman, Todd D Armstrong, Roisin M Connolly, Nilo A Azad,[...]. Cancer Immunol Res 2018
50
50

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.
Hong-Li Sun, Xin Zhou, Yi-Feng Xue, Ke Wang, Yun-Feng Shen, Jing-Jue Mao, Hong-Feng Guo, Zong-Ning Miao. World J Gastroenterol 2012
89
50

Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
Olivia Marini, Cecilia Spina, Elda Mimiola, Adriana Cassaro, Giovanni Malerba, Giuseppe Todeschini, Omar Perbellini, Maria Scupoli, Giuseppe Carli, Davide Facchinelli,[...]. Oncotarget 2016
43
50

Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.
Zhiqi Xie, Tamami Ikegami, Yukio Ago, Naoki Okada, Masashi Tachibana. Oncoimmunology 2020
8
50

Entinostat for the treatment of breast cancer.
Dario Trapani, Angela Esposito, Carmen Criscitiello, Luca Mazzarella, Marzia Locatelli, Ida Minchella, Saverio Minucci, Giuseppe Curigliano. Expert Opin Investig Drugs 2017
22
50

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
Trevor E Angell, Melissa G Lechner, Alison M Smith, Sue E Martin, Susan G Groshen, Dennis R Maceri, Peter A Singer, Alan L Epstein. Thyroid 2016
35
50

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.
Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, Mario P Colombo, Alan B Frey, Tim F Greten, Susanna Mandruzzato, Peter J Murray, Augusto Ochoa, Suzanne Ostrand-Rosenberg,[...]. Nat Commun 2016
50

Transcriptional regulation of myeloid-derived suppressor cells.
Thomas Condamine, Jérôme Mastio, Dmitry I Gabrilovich. J Leukoc Biol 2015
139
50

Combining epigenetic and immune therapy to overcome cancer resistance.
Stephanie Gomez, Tomasz Tabernacki, Julie Kobyra, Paige Roberts, Katherine B Chiappinelli. Semin Cancer Biol 2020
17
50



Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors.
Ayumi Hashimoto, Takeshi Fukumoto, Rugang Zhang, Dmitry Gabrilovich. Cancer Immunol Immunother 2020
10
50

GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.
Brent H Koehn, Petya Apostolova, Jessica M Haverkamp, Jeffrey S Miller, Valarie McCullar, Jakub Tolar, David H Munn, William J Murphy, Willie June Brickey, Jonathan S Serody,[...]. Blood 2015
66
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.